Group 1 - The board of directors of Yingluohua Technology Co., Ltd. held its 11th meeting of the 10th session on September 5, 2025, with all 9 directors present, complying with relevant regulations [1][2] - The board approved the election of Wei Zhonghua as the representative director to execute company affairs, effective immediately until the end of the current board's term [1][2] - The board also approved the adjustment of the members of the specialized committees due to changes in board membership, with new appointments for the Audit Committee, Nomination Committee, Strategy Committee, and Compensation and Assessment Committee [2]

Group 1 - The company held its 32nd meeting of the third board of directors on September 5, 2025, with all 7 directors present, complying with legal and regulatory requirements [1] - The board approved the proposal to sign a convertible bond investment agreement, which was previously reviewed and agreed upon by the audit committee [1][2] - The proposal will be submitted for approval at the company's third extraordinary general meeting of shareholders in 2025 [2] Group 2 - The board also approved the proposal to convene the third extraordinary general meeting of shareholders in 2025, with unanimous support from all directors [2]

Core Viewpoint - The company, Wuxi Xinhongye Cable Technology Co., Ltd., has approved a plan for a simplified procedure to issue shares to specific investors in 2025, aiming to raise funds for the development and industrialization of special cables for new-generation nuclear power plants. Group 1: Board Meeting Details - The second session of the company's second board meeting was held on September 5, 2025, with all seven directors present, meeting the legal requirements for a valid meeting [1]. - The meeting was convened by Chairman Mr. Bu Xiaohua and was attended by senior management [1]. Group 2: Share Issuance Plan - The company plans to issue shares to no more than 35 specific investors, including qualified institutional investors and individuals, following the approval from the China Securities Regulatory Commission (CSRC) [2]. - The shares will be issued at a price not lower than 80% of the average stock price over the 20 trading days prior to the pricing date [3]. - The total amount to be raised from this issuance is capped at 285 million yuan, with net proceeds allocated to specific projects [4]. Group 3: Fund Utilization - The funds raised will be used for the research and industrialization of special cables for new-generation nuclear power plants, with a total project investment of 319 million yuan [4]. - The company will initially use self-raised funds for the project until the raised funds are available, at which point the self-raised funds will be replaced [4]. Group 4: Regulatory Compliance and Reporting - The company has prepared various reports related to the share issuance, including feasibility analysis and the impact on immediate returns, which have been approved by the board [6][7][8]. - The board has also approved a report on the use of previously raised funds, which has been verified by an external accounting firm [9]. Group 5: Upcoming Shareholder Meeting - A third extraordinary general meeting of shareholders is scheduled for September 22, 2025, to discuss the approved proposals that require shareholder approval [8][10].

Group 1 - The board of directors of Ningbo Zhoushan Port Co., Ltd. held its 19th meeting of the 6th session, which was conducted via written signature and met the legal requirements for attendance [1][2] - The board unanimously approved the proposal to nominate Mr. Liu Jie as an independent director candidate for the 6th board, with his term starting from the approval date of the second extraordinary general meeting of shareholders in 2025 until the end of the board's term, with a maximum continuous term of six years for independent directors [1][2] Group 2 - The proposal was previously reviewed and approved by the board's nomination committee and was submitted for the board's consideration, with a voting result of 17 votes in favor, 0 against, and 0 abstentions [2] - Mr. Liu Jie, born in September 1963, holds a doctoral degree and is currently a professor and doctoral supervisor at Fudan University. He has extensive experience in various academic and corporate roles, including serving as an independent director for multiple companies [2]

证券代码：603657 证券简称:春光科技 公告编号：2025-050 金华春光橡塑科技股份有限公司 会议由监事会主席黄颜芳女士主持。 二、监事会会议审议情况 (一)、审议通过了《关于拟签订 <可转股债权投资协议> 的议案》 具体内容详见公司同日于指定信息披露媒体披露的《春光科技关于拟签订 <可转> 股债权投资协议>的公告》（公告编号：2025-051）。 表决结果：3票同意、0票弃权、0票反对。 该议案尚需提交公司 2025 年第三次临时股东大会审议。 特此公告。 金华春光橡塑科技股份有限公司监事会 第三届监事会第二十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、监事会会议召开情况 金华春光橡塑科技股份有限公司（以下简称"公司"）第三届监事会第二十三 次会议通知和会议材料于 2025 年 9 月 3 日以专人送达等方式发出。会议于 2025 年 规则》第七条规定"情况紧急，需要尽快召开监事会临时会议的，可以随时通过口 头或者电话等方式发出会议通知，但召集人应当在会议上作出说明"，本次会议已在 会议上作 ...

Group 1 - The core point of the announcement is the approval of the expected daily related transactions for the year 2025 by the company's supervisory board [1] - The related transactions involve the sale of pharmaceuticals and provision of production and research services to a related party, Hunan Hengchang Pharmaceutical Group Co., Ltd., by the company and its subsidiaries [1] - The transaction prices are based on market prices for similar businesses and are determined through friendly negotiations, ensuring fairness and reasonableness without adversely affecting the company's operations or harming the interests of minority shareholders [1] Group 2 - The supervisory board meeting was conducted in accordance with the Company Law and the company's articles of association, with all three participating supervisors voting in favor of the proposal [1] - The resolution received unanimous support with 3 votes in favor, 0 votes against, and 0 abstentions [1]

Group 1 - The board of directors of Hangzhou Xingshuai Electric Co., Ltd. held its 23rd meeting of the 5th session on September 5, 2025, with all 7 directors present, confirming the meeting's legality and effectiveness [1] - The board approved the election of Mr. Lou Yongwei as the representative director to execute company affairs, with a unanimous vote of 7 in favor, 0 against, and 0 abstentions [1] - The term for the newly elected representative director will last until the end of the current board's term [1] Group 2 - The board also approved the election of members and the convener of the audit committee, with a unanimous vote of 7 in favor, 0 against, and 0 abstentions [2] - The audit committee will consist of independent directors Mr. Luo Guoliang, Mr. Zeng Ronghui, and Mr. Li Xinggen, with Mr. Luo serving as the convener and being a professional accountant [2] - The term for the audit committee members will also last until the end of the current board's term [2]

Core Viewpoint - The company held its eighth board meeting of the tenth session, where significant decisions were made regarding the election of non-independent directors, the appointment of senior management, and amendments to the company's governance structure [1][2][3]. Group 1: Board Decisions - The board approved the election of two non-independent director candidates: Mr. Yao Chaofeng and Mr. Zeng Yiming, pending shareholder approval [2][3]. - The board unanimously agreed to appoint Mr. Zeng Yiming as the company's president, Mr. Li Jinjun as vice president, Mr. Tian Yuli as vice president and chief legal officer, and Mr. He Haihong as the financial director [2][3]. Group 2: Governance Structure Amendments - The company will no longer have a supervisory board; its functions will be transferred to the audit and risk committee of the board [3]. - The board approved amendments to the company's articles of association and various governance rules, which will also require shareholder approval [3][4]. Group 3: Management Structure Adjustments - The company plans to adjust its headquarters management structure to a "10+3" departmental model, consisting of 10 departments and 3 business units [5]. - The 10 departments include comprehensive management, audit, board office, human resources, financial management, market development, operational management, safety and environmental supervision, digital innovation, and overseas business [5]. Group 4: Upcoming Shareholder Meeting - The board approved the convening of the seventh extraordinary general meeting of shareholders in 2025, with details to be disclosed in various financial publications [6].

Group 1 - The company held a temporary board meeting where all five participating directors voted in favor of several key proposals [1][2][3] - The company plans to appoint Jiang Xin and Zhou Yanqi as non-independent directors, pending approval at the first temporary shareholders' meeting in 2025 [1][2] - The company intends to change its name to "Guhan Health Industry Group Co., Ltd." to better reflect its main business and enhance brand recognition [2][3] Group 2 - The company expects to engage in daily operational related transactions with its shareholder's affiliate, Hunan Hengchang Pharmaceutical Group Co., Ltd., with a total transaction amount not exceeding 50 million yuan in 2025 [2][3] - A temporary shareholders' meeting is scheduled for September 22, 2025, to discuss the aforementioned proposals [3][4] - All proposals from the board meeting require approval at the upcoming shareholders' meeting [4]

Core Points - The company has decided to amend its Articles of Association, eliminating the supervisory board and transferring its powers to the Audit and Risk Committee of the Board of Directors [1][2] - The resolution to amend the Articles of Association was passed unanimously by the supervisory board members present at the meeting [1] - The supervisory board will continue to fulfill its supervisory functions until the shareholders' meeting approves the amendments [2] Summary by Sections - **Meeting Details** - The 7th meeting of the 10th supervisory board was held on September 5, 2025, with all three supervisors present [1] - The meeting was conducted in accordance with the Company Law and the company's Articles of Association [1] - **Resolution Passed** - The supervisory board approved the proposal to amend the Articles of Association with a vote of 3 in favor, 0 against, and 0 abstentions [1] - The amendments are aimed at complying with relevant laws and regulations, including the Company Law and guidelines for listed companies [1] - **Future Actions** - The supervisory board will maintain its supervisory role until the shareholders' meeting reviews and approves the proposed amendments [2]